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Introduction: By maintaining sufficient cerebral blood flow and oxygenation, the goal of cardiopulmonary resuscitation
(CPR) is to preserve the pre-arrest neurological state. To date, cerebral monitoring abilities during CPR have been limited.
Therefore, we investigated the time-course of cerebral oxygen saturation values (rSO2) during advanced life support in
out-of-hospital cardiac arrest. Our primary aim was to compare rSO2 values during advanced life support from patients
with return of spontaneous circulation (ROSC) to patients who did not achieve ROSC.
Methods: We performed an observational study to measure rSO2 using Equanox™ (Nonin, Plymouth, MI) from the start
of advanced life support in the pre-hospital setting.
Results: rSO2 of 49 consecutive out-of-hospital cardiac arrest patients were analyzed. The total increase from initial
rSO2 value until two minutes before ROSC or end of advanced life support efforts was significantly larger in the
group with ROSC 16% (9 to 36) compared to the patients without ROSC 10% (4 to 15) (P = 0.02). Mean rSO2 from
the start of measurement until two minutes before ROSC or until termination of advanced life support was higher
in patients with ROSC than in those without, namely 39% ± 7 and 31% ± 4 (P = 0.05) respectively.
Conclusions: During pre-hospital advanced life support, higher increases in rSO2 are observed in patients attaining
ROSC, even before ROSC was clinically determined. Our findings suggest that rSO2 could be used in the future to guide
patient tailored treatment during cardiac arrest and could therefore be a surrogate marker of the systemic oxygenation
state of the patient.Introduction
The goal of cardiopulmonary resuscitation (CPR) is to
preserve the pre-arrest neurological state by maintaining
sufficient cerebral blood flow and oxygenation. By gener-
ating sufficient oxygenated blood flow, ischemic brain
damage is minimized [1]. However, only a minority of
patients following out-of hospital cardiac arrest (OHCA)
experience survival without neurological injury [2-4].
Good quality bystander basic life support, shorter time be-
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unless otherwise stated.increase the chance of survival with good neurological
outcome [5]. Unfortunately, it is still impossible to obtain
any information about organ perfusion, in particular cere-
bral perfusion, and ensuing ischemic organ damage during
CPR. Current monitoring of the OHCA patient during
CPR is limited to rhythm assessments, pulse checks be-
tween two episodes of chest compressions and end-
tidal carbon dioxide [6]. Currently, the latter is the only
parameter proven to correlate with the likelihood of re-
turn of spontaneous circulation (ROSC), although its
value for the prediction of long-term outcome has not
been established and gives no particular information
about the brain [7].
An ideal monitor during out-of hospital CPR should
be readily available for use, non-invasively, independent
of a pulsatile signal and should provide information
about the condition of the brain. Cerebral near-infraredtral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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sures the regional difference between oxygenated and
deoxygenated hemoglobin, an expression of the differ-
ence in oxygen supply and demand. NIRS is independent
of a pulsatile signal and continuously measures cerebral
oxygen saturation (rSO2) [8]. This technique has re-
cently been introduced in the cardiac arrest setting
[9-17]. These studies suggest that rSO2 measured during
CPR may correlate with ROSC and survival. Unfortu-
nately, all currently available data were obtained during
in-hospital CPR efforts of OHCA patients or during
CPR of in-hospital cardiac arrest patients. Until now, no
data are available on rSO2 monitoring from start of ad-
vanced life support (ALS) in patients suffering from
OHCA. The purpose of this study was to measure rSO2
in OHCA patients from the start of ALS until ROSC or
until the resuscitation efforts were terminated. We
aimed to investigate whether any difference existed in
the time course of rSO2 between patients who did or did
not experience ROSC.
Methods
In this prospective, observational, single-center study
(Ziekenhuis Oost-Limburg, Genk, Belgium) we mea-
sured pre-hospital rSO2 in consecutive OHCA patients.
The primary aim of this study was to investigate whether
there was any difference in rSO2 during OHCA ALS be-
tween patients who achieved ROSC and patients who do
not. Furthermore, the difference in highest, lowest and
initial rSO2 was also investigated as the proportion of
time during ALS spent below 30%. The study protocol
was approved by the local institutional review board
(Commissie Medische Ethiek Ziekenhuis Oost-Limburg,
13–044 U). Informed consent was obtained from patient’s
next of kin. In circumstances in which it was not possible
to obtain informed consent, the requirement for informed
consent was waived, in agreement with the protocol.
An emergency vehicle, staffed by a physician trained in
emergency medicine or anesthesiology and a nurse,
equipped with a portable cerebral oximeter (Equanox™
7600; Nonin Medical Inc., Plymouth, MN, USA) drove
to the scene of an OHCA after an emergency call. The
physician placed a single sensor on the right side of the
forehead of the patient as soon as possible, in some
cases immediately and in some cases after endotracheal
intubation. If the sensor was applied before endotracheal
intubation, 100% oxygen was delivered through a bag
valve mask. All patients were intubated and ventilated
with 100% oxygen. Only one rSO2 sensor was applied to
minimize the time delay to the gold standard of care.
rSO2 was continuously measured and registered every
4 seconds during pre-hospital ALS until CPR efforts
were terminated or until the patient with ROSC arrived
at the emergency department. ALS was performedfollowing current European Resuscitation guidelines [6].
In all patients, manual chest compressions were per-
formed. None of the patients received mechanical chest
compressions. If ROSC was achieved, the emergency
physician pressed the event button of the cerebral oxim-
eter and/or noted the time of ROSC on the Utstein
forms [18,19]. Patients were pronounced dead pre hos-
pital or they achieved sustained ROSC (>20 minutes)
and were transported to the hospital. No patient was
transported with ongoing CPR.
Exclusion criteria were age younger than 18, obvious
traumatic cause of cardiac arrest and ROSC before or
within 1 minute after start of rSO2 measurement. Emer-
gency physicians were not blinded to rSO2 values be-
cause visual confirmation of the measurement and
quality of the NIRS signal is necessary. However, they
had not received any pre-study information regarding
the interpretation of rSO2 values. The rSO2 values were
therefore not used in the clinical decision-making and
all patients received the best available care regardless of
rSO2 values. The decision to stop resuscitation efforts
was at the discretion of the medical emergency team.
The accuracy and reliability of the used cerebral oxim-
eter (Equanox™ 7600; Nonin Medical Inc.) has been vali-
dated against a mix of 70% jugular bulb saturation and
30% arterial saturation [20].
Baseline characteristics were prospectively collected
from Utstein templates and emergency medical charts
[18,19]. rSO2 data were downloaded from the portable
device according to the manufacturer’s instructions and
exported to SPSS 20.00 (SPSS, Armonk, NY, USA) for
statistical analysis. Patients were defined as achieving
ROSC if ROSC was sustained for more than 20 minutes.
Because the goal of this prospective study was to in-
vestigate the rSO2 values in OHCA patients during ALS
as a prediction for ROSC and to avoid interference from
rSO2 measurements when ROSC was already achieved,
only data obtained until 1 or 2 minutes before ROSC
were used in the following data analysis. We compared
initial, mean and maximum rSO2 values as well as the
increase in rSO2 and the percentage of ALS time spent
below a rSO2 value of 30%.
Statistical analysis
Patients’ characteristics were compared using Student’s t
test if normally distributed or the Mann–Whitney test if
not normally distributed and expressed as respectively
mean ± standard deviation or median with first and third
quartiles. The chi-square test and Fisher’s exact test were
used when comparing categorical values. Descriptive sta-
tistics were used for continuously measured rSO2 values
and are expressed as mean ± standard deviation or me-
dian with first and third quartiles. P <0.05 was consid-
ered statistically significant. All tests were performed
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Results
Between December 2011 and November 2013, there were
100 eligible OHCA patients. Out of these 100 patients, rSO2
was measured in 56 OHCA patients (Figure 1). Data for
seven patients were excluded from the analysis for the fol-
lowing reasons: obvious noncardiac cause of arrest (hanging)
in two patients, four patients already had ROSC when rSO2
measurement was started, and data from one patient couldFigure 1 Enrollment of study patients. ROSC, return of spontaneous circnot be used due to a technical defect during transfer of data.
Eventually 49 patients were prospectively included, 19 (39%)
patients achieved sustained ROSC whereas 30 patients
(61%) did not and died pre hospital. Of the 19 patients with
ROSC, 10 patients (20%) died in the emergency depart-
ment and eventually three (6%) patients survived with
good neurological outcome (Cerebral Performance
Category 1 and 2) at hospital discharge and one patient
survived with Cerebral Performance Category 4.
Comparing ROSC with no ROSC, there were signifi-
cantly more male patients in the group without ROSCulation.
Table 1 Patient demographics and characteristics
Total No ROSC ROSC P value
(n = 49) (n = 30) 19)
Male 31 (63) 23 (77) 8 (42) 0.03
Age 73 (±17) 69 (±17) 70 (16) 0.85
First recorded rhythm
Ventricular fibrillation 12 (24) 6 (20) 6 (32) 0.50
Asystole 31 (63) 20 (67) 11 (58) 0.56
Pulseless electric activity 6 (15) 4 (13) 2 (11) 1.00
Bystander witnessed cardiac arrest 26 (53) 14 (47) 12 (63) 0.38
EMS witnessed cardiac arrest 3 (6) 1 (3) 2 (11) 0.55
Bystander CPR 29 (59) 20 (67) 9 (47) 0.24
BLS duration (minutes)
Total 12 (9 to 16) 13 (10 to 16.75) 10 (4 to 12) 0.01
Bystander 10 (5.5 to 15) 10 (7.5 to 15) 5 (4 to 11.5) 0.02
Paramedic 6.5 (4 to 10) 8 (5 to 12) 4 (4 to 8.5) 0.03
ALS duration (minutes) 21 (15.5 to 31) 25 (20 to 32.75) 16 (10 to 30) 0.02
Response time (minutes)
Time (call to ALS) 13 (11 to 15) 14 (12 to 17.25) 12 (8 to 15) 0.01
Time (call to BLS) 0 (0 to 4) 0 (0 to 4.75) 2 (0 to 4) 0.48
Time (ALS to sensor placement) 3 (1 to 9) 5 (1.75 to 12) 2 (0 to 6) 0.15
Epinephrine dosage (mg) 5 (3 to 8) 5 (4 to 8) 4 (2 to 8) 0.11
Data are presented as number (percentage), mean (± standard deviation) or median (interquartile range). Demographic data of studied patients. ALS, advanced
life support; BLS, basic life support; CPR, cardiopulmonary resuscitation; EMS, emergency medical system; ROSC, return of spontaneous circulation.
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rest, amount of epinephrine given and the number of pa-
tients in which basic life support by bystanders was
started were similar in both groups (Table 1). Patients
with ROSC had a shorter median duration of basic lifeTable 2 Cerebral saturation values
No ROS
(n = 30)
Initial rSO2 20 % (±
Initial rSO2, lowest value of the first minute 19% (7
Initial rSO2, mean of the first minute 27% (14
Lowest rSO2 value 19% (7
Highest rSO2 value, ROSC included 40% (±1
Highest rSO2 until 2 minutes before ROSC 40% (±1
Mean rSO2, ROSC included 31% (±4
Mean rSO2 until 2 minutes before ROSC 31% (±4
Increase in rSO2, ROSC included 10% (4
Increase in rSO2 until 2 minutes before ROSC 10% (4
Increase in rSO2 until 16 minutes 11% (6
% time spent rSO2 ≤ 30%, ROSC included 25 (0 to
% time spent rSO2 ≤ 30% until 2 minutes before ROSC 25 (0 to
Parametric data expressed as mean (± standard deviation), nonparametric data as m
spontaneous circulation.support, initiated by bystander, general practitioners or
paramedics (10 (4 to 12) minutes vs. 13 (10 to 17) mi-
nutes, P <0.01) and shorter median duration of ALS (16
(10 to 30) minutes vs. 25 (20 to 33) minutes, P = 0.02).
The median time between the emergency call and theC ROSC P value
(n = 19)
13) 28% (±20) 0.07
to 30) 24% (8 to 39) 0.10
to 33) 35% (8 to 43) 0.11
to 3) 24 %(8 to 39) 0.14
6) 56% (±14) <0.01
6) 52% (±14) <0.01
) 42% (±8) 0.02
) 39% (±7) 0.05
to 15) 18% (15 to 33) <0.01
to 15) 16% (9 to 32) 0.02
to 19) (14 pts) 16% (11 to 36) (19 pts) 0.05
100) 1 (0 to 37) 0.03
100) 2 (0 to 36) 0.05
edian (interquartile range). rSO2, cerebral tissue saturation; ROSC, return of
Figure 2 Course of cerebral oxygen saturation during advanced
life support. Mean cerebral oxygen saturation (rSO2) values ± standard
error of mean during advanced life support (ALS) in patients with
return of spontaneous circulation (ROSC) and no ROSC.
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without ROSC and 12 (8 to 15) minutes in the group
with ROSC (P = 0.01).
The total median increase from initial rSO2 values until
2 minutes before ROSC or the end of ALS efforts was sig-
nificantly larger in the group with ROSC (16% (9 to 32))
compared with the patients without ROSC 10% (4 to 15)
(P = 0.02). All results are summarized in Table 2.
The median duration of ALS until ROSC was 16 (10
to 30) minutes. If we compare rSO2 from the start of
measurement until ROSC or until 16 minutes in the no
ROSC group (only available in 14 patients), a significant
difference in median increase is observed – namely 11%
(5.75 to 19) for the no ROSC group versus 16% (11 to
36) for the ROSC group (P = 0.05).
Patients who did not achieve ROSC spent a significantly
higher portion of time during ALS with rSO2 ≤ 30%
(P < 0.03). The median proportion of time spent ≤30%
until 2 minutes before ROSC was 25% (0 to 100) of
the time for the no ROSC group compared with 2% (0 to
36) of the time for the ROSC group (P = 0.05). Figure 2
represents the course of rSO2 values in both groups dur-
ing ALS.
The mean maximum rSO2 value until 2 minutes be-
fore ROSC recorded during ALS was significantly higher
in the group that achieved ROSC (52% ± 14 vs. 40% ± 16,
P <0.01). The median minimal rSO2 value recorded dur-
ing ALS, 24% (8 to 39) in the ROSC group compared
with 18% (7 to 29) in the no ROSC group, did not differ
(P = 0.14) between both groups.
There was no statistically significant difference in the
mean initial recorded rSO2 value between the ROSC
group compared with the no ROSC group (28% ± 20 vs.
20% ± 13, P = 0.07). The mean rSO2 over the first minute
after the start of measurement was not different betweenboth groups, 35% (8 to 43) in the ROSC group and 27%
(14 to 33) in the no ROSC group (P = 0.11).
The mean rSO2 from the start of measurement until
2 minutes before ROSC or until ALS was terminated was
higher in the ROSC group compared with the no ROSC
group, respectively 39% ± 7 and 31% ± 4 (P = 0.05).
The mean initial rSO2 value of the three patients with
good neurological outcome was 44% (±26). The mean
rSO2 until 2 minutes before ROSC was 54% (±4) and the
increase until 2 minutes before ROSC was 13% (±6).
Discussion
During pre-hospital ALS, a higher increase in rSO2 is
observed in patients attaining ROSC, even before ROSC
was clinically determined. rSO2 monitoring was started
immediately on the arrival of the medical emergency
team at the scene of cardiac arrest. During the entire
course of ALS, rSO2 values were recorded, until ROSC
or until the decision to stop ALS. Apart from three small
feasibility studies, all previously published studies on this
topic reported only data obtained in the emergency de-
partment, and therefore a considerable time after the
cardiac arrest [14,17,21]. As a result of our early pre-
hospital start of rSO2 monitoring, it was possible to
monitor patients with short ALS duration and a possibly
positive neurological outcome. The time delay between
start of CPR and rSO2 monitoring in all published stud-
ies was much longer, without information on the dur-
ation of low rSO2 values pre hospital and with exclusion
of OHCA patients with short time to ROSC [10].
As stated by others and in accordance with our results,
rSO2 seems more useful when it is used as a dynamic in-
formation tool rather than a static one, so that a single
threshold rSO2 value might be insufficient to predict
outcome [10,11,22]. However, use of the mean rSO2 as
the threshold is not clinically useful. We used data until
2 minutes before ROSC to enable a comparison of rSO2
during ALS between two equivalent groups of patients: a
first group who achieved ROSC and a second group in
which ALS efforts were halted, but both still in cardiac
arrest. We analyzed the difference in rSO2 increase dur-
ing ALS between patients who achieved ROSC and those
who did not. We found a significant difference in the in-
crease in rSO2 between these groups, with an increase in
rSO2 even before ROSC was clinically determined by
means of pulse check [23]. These observations support
the idea for the use of cerebral saturation as a monitor
during ALS. Asim and colleagues also analyzed the in-
crease in rSO2 during CPR, and found a gradual increase
of 5% (0 to 18) in the patients without ROSC compared
with 52% (17 to 52) (P <0.001) in the patients with ROSC
[16]. The higher increase, compared with our findings,
could be due to the device used to measure rSO2, the
Invos™ 5100C (Covidien, Boulder, CO, USA), which does
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rSO2 values at the moment of ROSC together with the ra-
ther small number of patients included (23 patients) will
exacerbate differences between survivors and nonsurvi-
vors. Thirdly, these findings are of limited added clinical
value because ROSC was already determined.
In addition to the increase from start of rSO2 meas-
urement until ROSC, a significant difference was also
observed between the ROSC group and the no ROSC
group if we compared the increase from start of ALS
until 16 minutes of ALS (median duration of ALS in the
ROSC group). Both findings could be a surrogate marker
for better systemic oxygenation with ROSC as a result.
These differences in the increase of rSO2 between the
ROSC group and the no ROSC group suggest a high
sensitivity of rSO2 to hemodynamic changes, which can
be important during ALS for early determination of
ROSC and rearrest, especially in the pre-hospital setting
where monitoring modalities are limited in contrast to
in-hospital cardiac arrest.
Analysis of the current results did not enable determin-
ation of a critical threshold of increase predicting ROSC
with acceptable specificity/sensitivity. Probably, larger pa-
tient numbers will be needed and our ongoing multicenter
trial (ClinicalTrials.gov NCT01806844) could enable us to
analyze whether this critical threshold for rSO2 increase
can be determined.
We observed no significant difference in initial rSO2
between patients who achieved ROSC and patients who
did not achieve ROSC. The absence of a significant dif-
ference in initial rSO2 between the ROSC group and the
no ROSC group was unexpected. We hypothesized that
patients with shorter time between the emergency call
and start of ALS would have a higher initial rSO2 value,
which in turn is supported by a significantly shorter time
between the emergency call and start of ALS in patients
achieving ROSC. The findings therefore seem contra-
dictory, but this could be linked to the relatively small
patient population studied and the observed trend for
higher initial rSO2 in the ROSC group. Initial rSO2 could
be clinically interesting because it is a fast and easy ob-
servation. Although only rSO2 data during CPR were in-
cluded, we were able to confirm the results of Parnia
and colleagues that patients with ROSC had a majority
of rSO2 values >30% during CPR [11]. Despite this con-
firmation, it is important to take into consideration that,
amongst our group of survivors, initial rSO2 values of
0% were measured.
In a recent multicenter study, Ito and colleagues mea-
sured rSO2 in 672 OHCA patients during a 1-minute
period at hospital arrival [15]. A significant difference
between patients with transient or sustained ROSC and
no ROSC was observed. Surprisingly, only the lowest
measured rSO2 values were used in their analysis,introducing a bias caused by suboptimal measurement.
It remains unclear how the authors processed rSO2
values <15% in their results because the NIRS device
used does not measure below rSO2 of 15% (Invos™
5100). As the study design is fundamentally different
and the measuring device (NIRS) is different, compari-
son with our study is not possible.
This study has several limitations. Firstly, it is a small,
observational, single-center study. Larger, multicenter
studies are necessary to confirm current results. Secondly,
the physician of the emergency medical team was not
blinded to the rSO2 values, although there are no indica-
tions that the rSO2 values were used in the decision to
cease or continue resuscitation efforts. Moreover, the
emergency physician did not receive any information
about interpretation of rSO2 data. Thirdly, despite the fact
that we used ROSC >20 minutes as the endpoint, only
nine patients survived until arrival at the ICU and eventu-
ally only four patients survived until hospital discharge.
Larger studies are necessary to compare rSO2 values dur-
ing ALS between survivors to hospital discharge and non-
survivors (neurological outcome). Fourthly, we could not
compare our findings with end-tidal capnography, which
is currently the only monitoring tool generally used during
CPR, due to lack of end-tidal carbon dioxide data. Finally,
none of the patients in the no ROSC group underwent an
autopsy, and therefore we can only presume an arrest of
cardiac origin.
Conclusion
We found a significant difference in increase of rSO2
during ALS between patients who achieved ROSC and
those who did not, even before ROSC was achieved. Our
findings suggest that rSO2 could become a surrogate
marker of systemic oxygenation because a significant in-
crease in rSO2 was observed before ROSC. Cerebral ox-
imetry could have the potential to guide treatment and
decision-making during cardiopulmonary resuscitation,
possibly together with capnography. Currently, no initial
rSO2 or gradient cutoff value can be defined to predict
ROSC. This will remain particularly difficult as high spe-
cificity is warranted for such a cutoff value, and observed
rSO2 values vary within a wide range. Although there is
no doubt that in the clinical (pre) hospital setting a tool
to quickly determine whether a patient will achieve
ROSC would prove invaluable, these results are promis-
ing – but there is still a way to go.
Key messages
 Limited information and monitoring possibilities are
available during ALS in the OCHA setting.
 Patients who achieve ROSC have a statistically
significant higher increase in cerebral saturation
Genbrugge et al. Critical Care  (2015) 19:112 Page 7 of 7from start of measurement until 2 minutes before
ROSC or until end of CPR efforts.
 Further research is necessary in larger patient
groups to explore the monitoring possibilities to
guide CPR efforts and to correlate cerebral
saturation values with neurological outcome.
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